HUE060237T2 - Szedoheptulóz alkalmazása gyulladás megelõzésére vagy kezelésére - Google Patents
Szedoheptulóz alkalmazása gyulladás megelõzésére vagy kezeléséreInfo
- Publication number
- HUE060237T2 HUE060237T2 HUE14711754A HUE14711754A HUE060237T2 HU E060237 T2 HUE060237 T2 HU E060237T2 HU E14711754 A HUE14711754 A HU E14711754A HU E14711754 A HUE14711754 A HU E14711754A HU E060237 T2 HUE060237 T2 HU E060237T2
- Authority
- HU
- Hungary
- Prior art keywords
- sedoheptulose
- inflammation
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13160443.1A EP2781219A1 (en) | 2013-03-21 | 2013-03-21 | Use of sedoheptulose for prevention or treatment of inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE060237T2 true HUE060237T2 (hu) | 2023-02-28 |
Family
ID=47901873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE14711754A HUE060237T2 (hu) | 2013-03-21 | 2014-03-21 | Szedoheptulóz alkalmazása gyulladás megelõzésére vagy kezelésére |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US9694026B2 (hu) |
| EP (2) | EP2781219A1 (hu) |
| JP (1) | JP6388635B2 (hu) |
| CN (2) | CN115364112A (hu) |
| AU (1) | AU2014234230B2 (hu) |
| BR (1) | BR112015023463A2 (hu) |
| CA (1) | CA2903151C (hu) |
| DK (1) | DK2976089T3 (hu) |
| ES (1) | ES2930249T3 (hu) |
| HU (1) | HUE060237T2 (hu) |
| MX (1) | MX2015013378A (hu) |
| NZ (1) | NZ711523A (hu) |
| PL (1) | PL2976089T3 (hu) |
| PT (1) | PT2976089T (hu) |
| WO (1) | WO2014147214A1 (hu) |
| ZA (1) | ZA201506396B (hu) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2781218A1 (en) | 2013-03-21 | 2014-09-24 | Medizinische Universität Wien | Use of sedoheptulose as a nutritional supplement |
| CN106309458A (zh) * | 2016-07-28 | 2017-01-11 | 中南大学湘雅医院 | 2‑脱氧‑d‑葡萄糖及其在药学上可接受的盐在制备治疗银屑病药物方面的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE78166T1 (de) | 1985-10-22 | 1992-08-15 | Silvetti Anthony N | Monosaccharide enthaltende zusammensetzung zum heilen von wunden. |
| JPH04335877A (ja) | 1991-05-13 | 1992-11-24 | Eimu:Kk | 十薬食品・飲料並びに製造法 |
| US9492582B2 (en) * | 2000-11-08 | 2016-11-15 | Fxs Ventures, Llc | Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
| US20090252834A1 (en) | 2004-05-10 | 2009-10-08 | Michael Griffin Hayek | Compositions comprising glucose anti-metabolites |
| ATE458409T1 (de) | 2004-07-30 | 2010-03-15 | Vb Medicare Pvt Ltd | Süssstoffzusammensetzung mit reduziertem kaloriengehalt |
| WO2006093848A2 (en) | 2005-02-28 | 2006-09-08 | Mcneil Nutritionals, Llc | Brown sugar substitute |
| JP5048238B2 (ja) * | 2005-11-16 | 2012-10-17 | エスエス製薬株式会社 | ウワウルシ乾燥エキス含有経口製剤 |
| GB0720516D0 (en) | 2007-10-18 | 2007-11-28 | Cadbury Schweppes Plc | Comestible products |
| KR100912277B1 (ko) * | 2007-11-21 | 2009-08-17 | 한국생명공학연구원 | 내열성 효소를 이용하여 세도헵툴로스를 제조하는 방법 |
| CN101919872B (zh) * | 2010-07-21 | 2011-12-07 | 广东粤龙药业有限公司 | 景酮糖酐在制备抗乙肝药物中的应用 |
| GB201303698D0 (en) | 2012-10-26 | 2013-04-17 | Tate & Lyle Ingredients | Sweetener syrups |
| CN103059071B (zh) * | 2013-01-08 | 2016-03-16 | 华东理工大学 | 一种单糖的纳滤分离方法 |
| EP2781218A1 (en) | 2013-03-21 | 2014-09-24 | Medizinische Universität Wien | Use of sedoheptulose as a nutritional supplement |
-
2013
- 2013-03-21 EP EP13160443.1A patent/EP2781219A1/en not_active Withdrawn
-
2014
- 2014-03-21 CN CN202211174309.3A patent/CN115364112A/zh active Pending
- 2014-03-21 MX MX2015013378A patent/MX2015013378A/es unknown
- 2014-03-21 PT PT147117543T patent/PT2976089T/pt unknown
- 2014-03-21 JP JP2016503672A patent/JP6388635B2/ja active Active
- 2014-03-21 PL PL14711754.3T patent/PL2976089T3/pl unknown
- 2014-03-21 BR BR112015023463A patent/BR112015023463A2/pt not_active Application Discontinuation
- 2014-03-21 EP EP14711754.3A patent/EP2976089B1/en active Active
- 2014-03-21 CA CA2903151A patent/CA2903151C/en active Active
- 2014-03-21 ES ES14711754T patent/ES2930249T3/es active Active
- 2014-03-21 US US14/778,850 patent/US9694026B2/en active Active
- 2014-03-21 NZ NZ711523A patent/NZ711523A/en unknown
- 2014-03-21 WO PCT/EP2014/055679 patent/WO2014147214A1/en active Application Filing
- 2014-03-21 CN CN201480028530.5A patent/CN105283188A/zh active Pending
- 2014-03-21 DK DK14711754.3T patent/DK2976089T3/da active
- 2014-03-21 HU HUE14711754A patent/HUE060237T2/hu unknown
- 2014-03-21 AU AU2014234230A patent/AU2014234230B2/en active Active
-
2015
- 2015-09-01 ZA ZA2015/06396A patent/ZA201506396B/en unknown
-
2017
- 2017-06-14 US US15/622,235 patent/US10660910B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US9694026B2 (en) | 2017-07-04 |
| NZ711523A (en) | 2020-09-25 |
| DK2976089T3 (da) | 2022-11-07 |
| ZA201506396B (en) | 2018-05-30 |
| US20170281661A1 (en) | 2017-10-05 |
| CA2903151C (en) | 2021-11-30 |
| EP2781219A1 (en) | 2014-09-24 |
| CA2903151A1 (en) | 2014-09-25 |
| CN115364112A (zh) | 2022-11-22 |
| PL2976089T3 (pl) | 2023-01-30 |
| BR112015023463A2 (pt) | 2017-07-18 |
| PT2976089T (pt) | 2022-11-22 |
| ES2930249T3 (es) | 2022-12-09 |
| MX2015013378A (es) | 2016-01-08 |
| US10660910B2 (en) | 2020-05-26 |
| EP2976089B1 (en) | 2022-08-17 |
| WO2014147214A1 (en) | 2014-09-25 |
| CN105283188A (zh) | 2016-01-27 |
| AU2014234230A1 (en) | 2015-09-17 |
| JP2016516077A (ja) | 2016-06-02 |
| JP6388635B2 (ja) | 2018-09-12 |
| EP2976089A1 (en) | 2016-01-27 |
| US20160045525A1 (en) | 2016-02-18 |
| AU2014234230B2 (en) | 2018-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273815B (en) | Secondary vaccine particles for the treatment of inflammation | |
| HK1224186A1 (zh) | 純闔家族型高膽固醇血症的治療 | |
| HK1219756A1 (zh) | 用於治療癌症的方法和組合物 | |
| IL240599A0 (en) | Combined treatment to treat the formation of acne | |
| HK1244711A1 (zh) | Hmgb1介導的炎症的治療 | |
| SG11201505220VA (en) | Prevention & treatment of neuropathy | |
| HK1220374A1 (zh) | 用於治療碳氧血紅蛋白血症的組合物和方法 | |
| ZA201603117B (en) | Withanolides useful for the treatment of neurodegenerative diseases | |
| HK1216391A1 (zh) | 組合治療 | |
| IL241096A0 (en) | Treatment methods | |
| EP2986294A4 (en) | COMPOUNDS FOR THE TREATMENT OF PAIN | |
| GB201607581D0 (en) | Treatment of cancer | |
| EP3104869A4 (en) | Treatment of pain | |
| ZA201506396B (en) | Use of sedoheptulose for prevention or treatment of inflammation | |
| HK1232118A1 (zh) | 癌症的治療 | |
| PL3016948T3 (pl) | 2-acyloaminotiazole do leczenia nowotworów | |
| EP2986295A4 (en) | COMPOUNDS FOR THE TREATMENT OF PAIN | |
| GB201322346D0 (en) | Combination treatment of cancer | |
| GB201317373D0 (en) | Treatment and prevention of cancer | |
| GB201322347D0 (en) | Treatment of cancer | |
| GB201318742D0 (en) | Treatment of cancer | |
| GB201308529D0 (en) | Treatment of cancer | |
| GB201305020D0 (en) | Treatment of cancer | |
| GB201309001D0 (en) | Methods for prevention and treatment of preeclampsia | |
| GB201320653D0 (en) | Treatment of plants |